Cotinga Pharmaceuticals Stock Forecast, Price & News

+0.01 (+9.09 %)
(As of 08/3/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume404 shs
Average Volume523 shs
Market Capitalization$2.64 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive COTQF News and Ratings via Email

Sign-up to receive the latest news and ratings for Cotinga Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Cotinga Pharmaceuticals logo

About Cotinga Pharmaceuticals

Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.80 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Cotinga Pharmaceuticals (OTCMKTS:COTQF) Frequently Asked Questions

What stocks does MarketBeat like better than Cotinga Pharmaceuticals?

Wall Street analysts have given Cotinga Pharmaceuticals a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cotinga Pharmaceuticals wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Cotinga Pharmaceuticals' earnings last quarter?

Cotinga Pharmaceuticals Inc. (OTCMKTS:COTQF) issued its earnings results on Wednesday, December, 18th. The company reported ($0.01) earnings per share for the quarter.
View Cotinga Pharmaceuticals' earnings history

How has Cotinga Pharmaceuticals' stock been impacted by COVID-19?

Cotinga Pharmaceuticals' stock was trading at $0.0450 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, COTQF stock has increased by 166.7% and is now trading at $0.12.
View which stocks have been most impacted by COVID-19

Who are Cotinga Pharmaceuticals' key executives?

Cotinga Pharmaceuticals' management team includes the following people:
  • Ms. Alison D. Silva, CEO, Pres & Director
  • Dr. Richard T. Ho, Chief Scientific Officer (Age 58, Pay $265.18k)
  • Mr. Victor Hugo C.M.A., C.P.A., Chief Financial Officer (Age 51)
  • Mr. Paul Papi, VP of Investor Relations

Who are some of Cotinga Pharmaceuticals' key competitors?

What is Cotinga Pharmaceuticals' stock symbol?

Cotinga Pharmaceuticals trades on the OTCMKTS under the ticker symbol "COTQF."

How do I buy shares of Cotinga Pharmaceuticals?

Shares of COTQF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cotinga Pharmaceuticals' stock price today?

One share of COTQF stock can currently be purchased for approximately $0.12.

How much money does Cotinga Pharmaceuticals make?

Cotinga Pharmaceuticals has a market capitalization of $2.64 million.

What is Cotinga Pharmaceuticals' official website?

The official website for Cotinga Pharmaceuticals is coti.theyatesnetwork.com.

Where are Cotinga Pharmaceuticals' headquarters?

Cotinga Pharmaceuticals is headquartered at 127 Main Street, Boston MA, 02129.

How can I contact Cotinga Pharmaceuticals?

Cotinga Pharmaceuticals' mailing address is 127 Main Street, Boston MA, 02129. The company can be reached via phone at 860-798-0816 or via email at [email protected]

This page was last updated on 8/4/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.